Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DAMMANN

Showing results (631-640 of 1,354) with videos related to

Pageof 136
Sort By:
Obesity (Silver Spring, Md.)|July 30, 2014
Obese children and adolescents need increased gastric volumes in order to perceive satietyIsabelle Mack, Helene Sauer, Katja Weimer, et al.
Regulatory Toxicology and Pharmacology : RTP|July 15, 2014
Effect of estrogenic binary mixtures in the yeast estrogen screen (YES)Tzutzuy Ramirez, Andreas Buechse, Martina Dammann, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 14, 2016
Systemic endogenous erythropoietin and associated disorders in extremely preterm newbornsMari Holm, Jon Skranes, Olaf Dammann, et al.
Cancer Research|July 5, 2002
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinomaUndraga Schagdarsurengin, Oliver Gimm, Cuong Hoang-Vu, et al.
Archives of Toxicology|July 19, 1977
Rat liver changes after subchronic exposition to polychlorinated biphenyls (PCB) of low chlorine contentA Schmoldt, E Altenähr, W Grote, et al.
Journal of Clinical Psychopharmacology|April 26, 2020
Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant SchizophreniaMaxim Kuzin, Benjamin Bochon, Efstratios Vagiaris, et al.
Molecular and Cellular Biology|May 5, 2005
Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoterMaria Strunnikova, Undraga Schagdarsurengin, Astrid Kehlen, et al.
Molecular Cancer|October 6, 2010
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequencesUndraga Schagdarsurengin, Antje M Richter, Juliane Hornung, et al.
Current Biology : CB|March 24, 2007
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor networkCai Guo, Stella Tommasi, Limin Liu, et al.
Arzneimittel-Forschung|November 1, 1986
[The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man]H G Dammann, M Rehner, M Dreyer, et al.
Pageof 136

Showing results (631-640 of 1,354) with videos related to

Sort By:
Pageof 136
Obesity (Silver Spring, Md.)|July 30, 2014
Obese children and adolescents need increased gastric volumes in order to perceive satietyIsabelle Mack, Helene Sauer, Katja Weimer, et al.
Regulatory Toxicology and Pharmacology : RTP|July 15, 2014
Effect of estrogenic binary mixtures in the yeast estrogen screen (YES)Tzutzuy Ramirez, Andreas Buechse, Martina Dammann, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|May 14, 2016
Systemic endogenous erythropoietin and associated disorders in extremely preterm newbornsMari Holm, Jon Skranes, Olaf Dammann, et al.
Cancer Research|July 5, 2002
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinomaUndraga Schagdarsurengin, Oliver Gimm, Cuong Hoang-Vu, et al.
Archives of Toxicology|July 19, 1977
Rat liver changes after subchronic exposition to polychlorinated biphenyls (PCB) of low chlorine contentA Schmoldt, E Altenähr, W Grote, et al.
Journal of Clinical Psychopharmacology|April 26, 2020
Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant SchizophreniaMaxim Kuzin, Benjamin Bochon, Efstratios Vagiaris, et al.
Molecular and Cellular Biology|May 5, 2005
Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoterMaria Strunnikova, Undraga Schagdarsurengin, Astrid Kehlen, et al.
Molecular Cancer|October 6, 2010
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequencesUndraga Schagdarsurengin, Antje M Richter, Juliane Hornung, et al.
Current Biology : CB|March 24, 2007
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor networkCai Guo, Stella Tommasi, Limin Liu, et al.
Arzneimittel-Forschung|November 1, 1986
[The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man]H G Dammann, M Rehner, M Dreyer, et al.
Pageof 136